Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antibody responses to SARS-CoV-2 in patients with differing severities of coronavirus disease 2019
Ekasit Kowitdamrong, Thanyawee Puthanakit, Watsamon Jantarabenjakul, et al.
PLoS ONE (2020) Vol. 15, Iss. 10, pp. e0240502-e0240502
Open Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study
Max Augustin, Philipp Schommers, Melanie Stecher, et al.
The Lancet Regional Health - Europe (2021) Vol. 6, pp. 100122-100122
Open Access | Times Cited: 639
Paper-based electrochemical biosensor for diagnosing COVID-19: Detection of SARS-CoV-2 antibodies and antigen
Abdulhadee Yakoh, Umaporn Pimpitak, Sirirat Rengpipat, et al.
Biosensors and Bioelectronics (2020) Vol. 176, pp. 112912-112912
Open Access | Times Cited: 454
Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Michael J. Peluso, Scott Lu, Alex Tang, et al.
The Journal of Infectious Diseases (2021) Vol. 224, Iss. 11, pp. 1839-1848
Open Access | Times Cited: 263
Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms
Michael J. Peluso, Amelia N. Deitchman, Leonel Torres, et al.
Cell Reports (2021) Vol. 36, Iss. 6, pp. 109518-109518
Open Access | Times Cited: 200
Antibody tests for identification of current and past infection with SARS-CoV-2
Tilly Fox, Julia Geppert, Jacqueline Dinnes, et al.
Cochrane library (2022) Vol. 2022, Iss. 11
Open Access | Times Cited: 177
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay
Michael J. Peluso, Saki Takahashi, Jill Hakim, et al.
Science Advances (2021) Vol. 7, Iss. 31
Open Access | Times Cited: 139
Antibody Responses in COVID-19: A Review
Mateo Chvatal-Medina, Yorjagis Mendez-Cortina, Pablo Javier Patiño Grajales, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 137
Longitudinal follow-up of IgG anti-nucleocapsid antibodies in SARS-CoV-2 infected patients up to eight months after infection
Jan Van Elslande, Matthijs Oyaert, Scott Ailliet, et al.
Journal of Clinical Virology (2021) Vol. 136, pp. 104765-104765
Open Access | Times Cited: 136
Seroprevalence of SARS-CoV-2 (COVID-19) exposure in pet cats and dogs in Minnesota, USA
Mythili Dileepan, Da Di, Qinfeng Huang, et al.
Virulence (2021) Vol. 12, Iss. 1, pp. 1597-1609
Open Access | Times Cited: 82
Less severe course of COVID-19 is associated with elevated levels of antibodies against seasonal human coronaviruses OC43 and HKU1 (HCoV OC43, HCoV HKU1)
Martin Dugas, Tanja Grote-Westrick, Richard Vollenberg, et al.
International Journal of Infectious Diseases (2021) Vol. 105, pp. 304-306
Open Access | Times Cited: 50
Surveilling and Tracking COVID-19 Patients Using a Portable Quantum Dot Smartphone Device
Yuwei Zhang, Ayden Malekjahani, Buddhisha Udugama, et al.
Nano Letters (2021) Vol. 21, Iss. 12, pp. 5209-5216
Closed Access | Times Cited: 47
IgA and FcαRI: Versatile Players in Homeostasis, Infection, and Autoimmunity
Melissa M.J. van Gool, Marjolein van Egmond
ImmunoTargets and Therapy (2021) Vol. Volume 9, pp. 351-372
Open Access | Times Cited: 41
A non-invasive ultrasensitive diagnostic approach for COVID-19 infection using salivary label-free SERS fingerprinting and artificial intelligence
Varsha Karunakaran, Manu M. Joseph, Induprabha Yadev, et al.
Journal of Photochemistry and Photobiology B Biology (2022) Vol. 234, pp. 112545-112545
Open Access | Times Cited: 28
Explaining Racial and Ethnic Inequities in SARS-CoV-2-Related Outcomes: Results from a Serosurvey in Chicago
Catherine Eyo, Joshua M. Schrock, Christina Hayford, et al.
Journal of Racial and Ethnic Health Disparities (2025)
Closed Access
Nationwide seroprevalence of antibodies against SARS-CoV-2 in Israel
Shay Reicher, Ronit Ratzon, Shay Ben-Sahar, et al.
European Journal of Epidemiology (2021) Vol. 36, Iss. 7, pp. 727-734
Open Access | Times Cited: 39
Impact of SARS-CoV-2 infection on the profiles and responses of innate immune cells after recovery
Vichaya Ruenjaiman, Pimpayao Sodsai, Patipark Kueanjinda, et al.
Journal of Microbiology Immunology and Infection (2022) Vol. 55, Iss. 6, pp. 993-1004
Open Access | Times Cited: 24
Neutrophil Extracellular Traps in Severe SARS-CoV-2 Infection: A Possible Impact of LPS and (1→3)-β-D-glucan in Blood from Gut Translocation
Supichcha Saithong, Navaporn Worasilchai, Wilasinee Saisorn, et al.
Cells (2022) Vol. 11, Iss. 7, pp. 1103-1103
Open Access | Times Cited: 23
Perspective: diagnostic laboratories should urgently develop T cell assays for SARS-CoV-2 infection
Rohan Ameratunga, See-Tarn Woon, A. M. Jordan, et al.
Expert Review of Clinical Immunology (2021) Vol. 17, Iss. 5, pp. 421-430
Closed Access | Times Cited: 30
Impact of reproduction number on the multiwave spreading dynamics of COVID-19 with temporary immunity: A mathematical model
B. Shayak, Mohit Sharma, Manas Gaur, et al.
International Journal of Infectious Diseases (2021) Vol. 104, pp. 649-654
Open Access | Times Cited: 28
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay
Michael J. Peluso, Saki Takahashi, Jill Hakim, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 28
Does Seeing What Others Do Through Social Media Influence Vaccine Uptake and Help in the Herd Immunity Through Vaccination? A Cross-Sectional Analysis
Abrar Al-Hasan, Jiban Khuntia, Dobin Yim
Frontiers in Public Health (2021) Vol. 9
Open Access | Times Cited: 27
A stronger antibody response in increased disease severity of SARS-CoV-2
Marta Iglis de Oliveira, Melayne Rocha Aciole, Patrícia Areias Feitosa Neves, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
The (apparent) antibody paradox in COVID-19
Rohan Ameratunga, See‐Tarn Woon, Edward Lea, et al.
Expert Review of Clinical Immunology (2022) Vol. 18, Iss. 4, pp. 335-345
Open Access | Times Cited: 15
Effectiveness of SARS-CoV-2 Vaccines for Short- and Long-Term Immunity: A General Overview for the Pandemic Contrast
Alessio Danilo Inchingolo, Giuseppina Malcangi, Sabino Ceci, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8485-8485
Open Access | Times Cited: 15
Low seroprevalence of COVID-19 in Lao PDR, late 2020
Siriphone Virachith, Virginie Pommelet, Elodie Calvez, et al.
The Lancet Regional Health - Western Pacific (2021) Vol. 13, pp. 100197-100197
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top